BMO Capital on Acadia Pharmaceuticals (ACAD): 'IP Protection Pushes Target to $28'
Go back to BMO Capital on Acadia Pharmaceuticals (ACAD): 'IP Protection Pushes Target to $28'| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 29.45 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.45 | 52 Week High | $42.49 | |||
| Open | $29.45 | 52 Week Low | $16.64 | |||
| Day High | $29.45 | P/E | N/A | |||
| Day Low | $29.45 | EPS | $-0.42 | |||
| Volume | 10,137 | |||||
